REGENERON PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tarrytown, NY
SEC filing record 1 source field available
Fiscal year end
31 December
REGENERON PHARMACEUTICALS, INC. has filed 2,449 SEC EDGAR filings since 26 Jul 1995

SEC filing history

Showing 151-175 of 1,000 matching filings.

Per page
25
Current page
7
4

PRIMARY DOCUMENT

Filing date
02 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
01 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Jun 2024
Reporting date
24 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Jun 2024
Reporting date
24 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
24 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Jun 2024
Reporting date
14 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
14 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
12 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jun 2024
Reporting date
10 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jun 2024
Reporting date
10 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Jun 2024
Reporting date
06 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
06 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
05 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
03 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
29 May 2024
Reporting date
28 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
28 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
21 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .